Allscripts entered into a definitive agreement to acquire McKesson’s health IT business last month. To investigate customers’ attitudes toward the announcement, KLAS Research surveyed current McKesson Paragon EHR customers from 38 organizations.
Here’s how respondents indicated the acquisition affected their future EHR plans.
1. Those who planned to give up the Paragon EHR under McKesson and still plan to find a new vendor: 39 percent
2. Those who planned to keep the Paragon EHR under McKesson and still plan to keep it under Allscripts: 37 percent
3. Those who planned to give up the Paragon EHR under McKesson but are reconsidering their decision: 13 percent
4. Those who planned to keep the Paragon EHR under McKesson but are reconsidering their decision: 11 percent
The 11 percent who planned to stay with McKesson but are now reconsidering the Paragon EHR under Allscripts cited poor past experiences with Allscripts and uncertainty with Allscripts developing two EHR platforms.
More articles on EHRs:
61% of healthcare officials indicate terrible, poor ROI on EHRs, survey finds
Allscripts wants to embed prices into prescribing workflow
Mayo Clinic adds symptoms assessment tool to Epic patient portal
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
